Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen (Q46319065)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen |
scientific article |
Statements
1 reference
Treatment of resistant human colon cancer xenografts by a fluoxetine-doxorubicin combination enhances therapeutic responses comparable to an aggressive bevacizumab regimen (English)
1 reference
Rimona Margalit
1 reference
Mirit Argov
1 reference
Rina Kashi
1 reference
Dan Peer
1 reference
11 October 2008
1 reference
1 reference
274
1 reference
1
1 reference
118-125
1 reference